-
JPM26: Pfizer Fast-Tracks Obesity Programs in Race Against Patent Cliff
13 Jan 2026 14:36 GMT
… the patent cliff facing Pfizer. Basic U.S. product patents on seven Pfizer franchises … following in 2027.
Pfizer’s products with patent losses in 2026 and … its injectables.
Pfizer’s strategy for offsetting its patent cliff extends beyond …
-
JPM26: BMS places confidence in core pipeline to weather 2030 patent cliff
13 Jan 2026 14:05 GMT
… profits towards 2030 despite looming patent expiries for revenue leaders Opdivo … ) and Eliquis (apixaban) as their patents near expiry.
Discover B2B Marketing … acquisitions to weather patent expiries, such as with Pfizer’s $10bn acquisition …
-
<![CDATA[J.P. Morgan 2026: Pfizer’s Pivot from Covid to Pipeline Execution ]]>
13 Jan 2026 01:45 GMT
… to exit the looming patent cycle with renewed growth … by execution, noting that Pfizer delivered three consecutive quarterly … asked about Pfizer’s confidence heading into the patent-expiry period … are no catalysts for Pfizer.”
Pfizer Inc 44th Annual J. …
-
JPM26: US biotech’s ‘Sputnik moment,’ Pfizer’s obesity ambitions and Bristol Myers’ big year
13 Jan 2026 00:43 GMT
… pace could quickly change. Patent expirations should threaten some of … added. — Gwendolyn Wu
Pfizer’s obesity ambitions
After winning … a commercial segment he said Pfizer understands well. “When we … differentiated,” he said. But Pfizer’s commercial might is “ …
-
Pfizer CEO plans for soaring consumer market for obesity drugs akin to Viagra
13 Jan 2026 00:05 GMT
… initially announced in September 2025, Pfizer did not expect the cash … not reimbursed at all." Pfizer developed and sold Viagra, … expertise in discovery." Pfizer has said it expects the … due to the expiration of patents on key drugs, lower sales …
-
From cornfields to COVID-19 shots: Monsanto’s patent war enters the vaccine arena
12 Jan 2026 14:06 GMT
… layer to existing mRNA patent wars, highlighting how scientific … to the lawsuits, the patents covering these stabilization techniques are … infringed Monsanto's patents to "enhance the … in an ongoing patent battle with Pfizer and BioNTech, claiming …
-
The Succeeding Patent Edge: Strategic Implications for Pharma Revenue, Portfolios and Innovation
12 Jan 2026 13:26 GMT
… Squibb and Pfizer. This will further move towards the U.S. patent… Pharma & Pfizer’s Xtandi has different expiration years for patent, such as … Keytruda, which encompasses approximately 300 patent applications that cover various indications …
-
Pfizer’s BRAFTOVI® Regimen with Additional Chemotherapy Backbone Increased Response Rates for Certain Patients with Metastatic Colorectal Cancer
10 Jan 2026 15:30 GMT
… Legos, Chief Oncology Officer, Pfizer. “These results underscore the … Prescribing Information.
About Pfizer Oncology
At Pfizer Oncology, we are … us on X at @Pfizer and @Pfizer News, LinkedIn, YouTube … and www.pfizer.com.
ERBITUX® is a registered trademark of …
-
JPM26: Paying cash for obesity drugs, renewed IPO optimism and pharma’s cell therapy view
14 Jan 2026 21:03 GMT
… with oral obesity medications. And Pfizer CEO Albert Bourla noted how … . Another, Metsera, was acquired by Pfizer.
IPOs, then, could rebound in … Paris-based Sofinnova Partners. “The patent cliff is still there, so …
-
Inside The J.P. Morgan Healthcare Extravaganza
14 Jan 2026 21:27 GMT
… , Big Pharma faces a coming “patent cliff” for numerous blockbuster drugs … Eliquis (Bristol Myers Squibb and Pfizer’s blood thinner). For another …
About
© 1995-2026